Chromophobe Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Chromophobe Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 study of nivolumab in combination with cabozantinib in patients with non-clear cell renal cell carcinoma; the trial is currently act…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) [Phase 2]
Phase 2 study UNICAB evaluating cabozantinib in various non-clear cell renal cell carcinoma subtypes after immunotherapy has been completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) [Phase 2]
Phase II trial investigating sequential single-agent nivolumab followed by combination ipilimumab plus nivolumab in metastatic or unresectab…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial results for Pazopanib hydrochloride in metastatic or recurrent kidney cancers have been posted after the study completed, incl…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating the combination of sorafenib tosylate and bevacizumab in advanced renal cell carcinoma, with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.